eFFECTOR Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: eFFECTOR Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q1 2024.
eFFECTOR Therapeutics, Inc. Assets for the quarter ending March 31, 2024 was $27.1M, a 23.7% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$27.1M	+$5.2M	+23.7%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$20.5M	-$8.53M	-29.3%	Dec 31, 2023	10-Q	2024-05-09
Q3 2023	$20.2M	-$16.5M	-45%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$26.9M	-$16.6M	-38.1%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$21.9M	-$27.6M	-55.7%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$29.1M	-$25M	-46.2%	Dec 31, 2022	10-K	2024-03-26
Q3 2022	$36.7M	-$23.3M	-38.9%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$43.5M	+$29.2M	+204%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$49.5M	-$127M	-72%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$54.1M	+$37.4M	+224%	Dec 31, 2021	10-K	2023-03-08
Q3 2021	$59.9M			Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$14.3M			Jun 30, 2021	8-K	2021-08-31
Q1 2021	$177M			Mar 31, 2021	10-Q	2021-06-03
Q4 2020	$16.7M			Dec 31, 2020	10-K	2022-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.